Physician profile
Howard Jay Korman
NPI 1467433599
$651.75
in general payments reported to CMS, 2019-2025
15 companies · $94.77 in 2025
The $94.77 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $12.95 · 2021: $151 · 2022: $59.48 · 2023: $70.86 · 2025: $94.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $113.69 | 2019 | |
| Astellas Pharma US INC | $109.98 | 2019-2021 | |
| Amgen INC. | $93.17 | 2019 | |
| Boston Scientific Corporation | $69.38 | 2021-2023 | Rezum Generator |
| Myriad Genetic Laboratories, INC. | $40.60 | 2022-2023 | Prolaris |
| Abbvie INC. | $38.34 | 2021 | |
| Avation Medical, INC. | $36.84 | 2025 | Vivally System |
| Avyxa Pharma, LLC | $29.71 | 2025 | |
| Ambu INC. | $28.22 | 2025 | |
| Analogic Corporation | $26.55 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $20.00 | 2022 | |
| Curium US LLC | $18.85 | 2023 | |
| Olympus America INC. | $13.47 | 2023 | Itind System |
| Coloplast Corp | $12.95 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Korman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.